124 related articles for article (PubMed ID: 35730828)
1. Decision criteria for resource allocation: an analysis of CONITEC oncology reports.
Campolina AG; Yuba TY; Soárez PC
Cien Saude Colet; 2022 Jul; 27(7):2563-2572. PubMed ID: 35730828
[TBL] [Abstract][Full Text] [Related]
2. Challenges to decision-making processes in the national HTA agency in Brazil: operational procedures, evidence use and recommendations.
Yuba TY; Novaes HMD; de Soárez PC
Health Res Policy Syst; 2018 May; 16(1):40. PubMed ID: 29751764
[TBL] [Abstract][Full Text] [Related]
3. Multicriteria decision analysis (MCDA) for health technology assessment: the Queensland Health experience.
Howard S; Scott IA; Ju H; McQueen L; Scuffham PA
Aust Health Rev; 2019 Oct; 43(5):591-599. PubMed ID: 30205873
[TBL] [Abstract][Full Text] [Related]
4. Health technology assessment in Brazil - an international perspective.
Lima SGG; Brito C; Andrade CJC
Cien Saude Colet; 2019 May; 24(5):1709-1722. PubMed ID: 31166506
[TBL] [Abstract][Full Text] [Related]
5. [Multi-criteria decision analysis for health technology resource allocation and assessment: so far and so near?].
Campolina AG; Soárez PC; Amaral FVD; Abe JM
Cad Saude Publica; 2017 Oct; 33(10):e00045517. PubMed ID: 29091169
[TBL] [Abstract][Full Text] [Related]
6. Exploring the COVID-19 Pandemic's Impact on the Health Technology Assessment Process of the National Commission for the Incorporation of Technologies Into the Brazilian Health System.
Cardoso MMA; Thabane L; Andrade LGM; Curado DDSP; Komoda DS; Machado-Rugolo J; Lima SAM; Weber SAT
Value Health Reg Issues; 2023 Sep; 37():18-22. PubMed ID: 37196546
[TBL] [Abstract][Full Text] [Related]
7. Health technology assessment and judicial deference to priority-setting decisions in healthcare: Quasi-experimental analysis of right-to-health litigation in Brazil.
Wang D; Vasconcelos NP; Poirier MJ; Chieffi A; Mônaco C; Sritharan L; Van Katwyk SR; Hoffman SJ
Soc Sci Med; 2020 Nov; 265():113401. PubMed ID: 33250316
[TBL] [Abstract][Full Text] [Related]
8. A model-based study to estimate the health and economic impact of health technology assessment in Thailand.
Kingkaew P; Budtarad N; Khuntha S; Barlow E; Morton A; Isaranuwatchai W; Teerawattananon Y; Painter C
Int J Technol Assess Health Care; 2022 May; 38(1):e45. PubMed ID: 35506420
[TBL] [Abstract][Full Text] [Related]
9. Incorporation of new medicines by the National Commission for Incorporation of Technologies, 2012 to June 2016.
Caetano R; Silva RMD; Pedro ÉM; Oliveira IAG; Biz AN; Santana P
Cien Saude Colet; 2017 Aug; 22(8):2513-2525. PubMed ID: 28793068
[TBL] [Abstract][Full Text] [Related]
10. The impact of health technology assessment reports on decision making in Austria.
Zechmeister I; Schumacher I
Int J Technol Assess Health Care; 2012 Jan; 28(1):77-84. PubMed ID: 22233544
[TBL] [Abstract][Full Text] [Related]
11. Case studies that illustrate disinvestment and resource allocation decision-making processes in health care: a systematic review.
Polisena J; Clifford T; Elshaug AG; Mitton C; Russell E; Skidmore B
Int J Technol Assess Health Care; 2013 Apr; 29(2):174-84. PubMed ID: 23514665
[TBL] [Abstract][Full Text] [Related]
12. TESTING MULTI-CRITERIA DECISION ANALYSIS FOR MORE TRANSPARENT RESOURCE-ALLOCATION DECISION MAKING IN COLOMBIA.
Castro Jaramillo HE; Goetghebeur M; Moreno-Mattar O
Int J Technol Assess Health Care; 2016 Jan; 32(4):307-314. PubMed ID: 27691990
[TBL] [Abstract][Full Text] [Related]
13. Health technology reassessment in the Brazilian public health system: Analysis of the current status.
Pereira VC; Barreto JOM; Neves FADR
PLoS One; 2019; 14(7):e0220131. PubMed ID: 31356609
[TBL] [Abstract][Full Text] [Related]
14. Heterogeneous Recommendations for Oncology Products Among Different HTA Systems: A Comparative Assessment.
Jarosławski S; Hanna E; Dabbous M; Chachoua L; Toumi M
Recent Results Cancer Res; 2019; 213():39-55. PubMed ID: 30543006
[TBL] [Abstract][Full Text] [Related]
15. HTA Agencies Need Evidence-Informed Deliberative Processes Comment on "Use of Evidence-Informed Deliberative Processes by Health Technology Assessment Agencies Around the Globe".
Schlander M
Int J Health Policy Manag; 2021 Mar; 10(3):158-161. PubMed ID: 32610783
[TBL] [Abstract][Full Text] [Related]
16. HEALTH TECHNOLOGY ASSESSMENT FOR DECISION MAKING IN LATIN AMERICA: GOOD PRACTICE PRINCIPLES.
Pichon-Riviere A; Soto NC; Augustovski FA; García Martí S; Sampietro-Colom L
Int J Technol Assess Health Care; 2018 Jan; 34(3):241-247. PubMed ID: 29888696
[TBL] [Abstract][Full Text] [Related]
17. Incorporation of drugs for rare diseases in Brazil: is it possible to have full access to these patients?
Biglia LV; Mendes SJ; Lima TM; Aguiar PM
Cien Saude Colet; 2021 Nov; 26(11):5547-5560. PubMed ID: 34852089
[TBL] [Abstract][Full Text] [Related]
18. Resource allocation and health technology assessment in Australia: views from the local level.
Gallego G; van Gool K; Kelleher D
Int J Technol Assess Health Care; 2009 Apr; 25(2):134-40. PubMed ID: 19331706
[TBL] [Abstract][Full Text] [Related]
19. Multicriteria decision analysis in health care decision in oncology: a systematic review.
Campolina AG; Suzumura EA; Hong QN; de Soárez PC
Expert Rev Pharmacoecon Outcomes Res; 2022 Apr; 22(3):365-380. PubMed ID: 34913775
[TBL] [Abstract][Full Text] [Related]
20. Key principles for the improved conduct of health technology assessments for resource allocation decisions.
Drummond MF; Schwartz JS; Jönsson B; Luce BR; Neumann PJ; Siebert U; Sullivan SD
Int J Technol Assess Health Care; 2008; 24(3):244-58; discussion 362-8. PubMed ID: 18601792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
